𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study

✍ Scribed by P. Comella; B. Massidda; S. Palmeri; A. Farris; L. De Lucia; D. Natale; L. Maiorino; S. Tafuto; G. De. Cataldis; R. Casaretti

Publisher
Springer
Year
2005
Tongue
English
Weight
190 KB
Volume
56
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Capecitabine plus oxaliplatin for the fi
Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma : Final results of the Southern Italy Cooperative Oncology Group Trial 0108
✍ Pasquale Comella; Donato Natale; Antonio Farris; Antonio Gambardella; Luigi Maio πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 116 KB

## Abstract ## BACKGROUND In patients with metastatic colorectal carcinoma (MCC), capecitabine has demonstrated a superior response rate (RR), equivalent disease progression‐free (PFS) and overall survival (OS), and an improved overall tolerability profile compared with bolus 5‐fluorouracil/leucov

The combination of gemcitabine and carbo
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma : A Phase II study of the Hellenic Cooperative Oncology Group
✍ Aristotle Bamias; Lia A. Moulopoulos; Aggelos Koutras; Gerassimos Aravantinos; G πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 132 KB

## Abstract ## BACKGROUND The toxicity of platinum‐based combinations represents a common problem for patients with advanced urothelial carcinoma. The authors previously reported encouraging efficacy for the combination of carboplatin and gemcitabine in patients considered to be unfit for cisplati